SEC Form 4 · accession 0001127602-15-007937
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Clackson
Officer — President, R&D, CSO
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 24,999 | $2.62 | A | 453,231 | D | |
| Common Stock | Feb 20, 2015 | S | 24,999 | $8.00 | D | 428,232 | D | |
| Common Stock | Feb 20, 2015 | M | 24,036 | $4.49 | A | 452,268 | D | |
| Common Stock | Feb 20, 2015 | S | 24,036 | $8.00 | D | 428,232 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $2.62 | Feb 20, 2015 | M | 24,999 | D | Dec 8, 2009 | Dec 8, 2019 | Common Stock | 24,999 | 0 | D |
| Employee Stock Option (Right to Buy) | $4.49 | Feb 20, 2015 | M | 24,036 | D | Apr 16, 2008 | Apr 16, 2017 | Common Stock | 24,036 | 31,422 | D |
Explanation of responses
- F1Shares were acquired upon the exercise of outstanding stock options at $2.62 per share.
- F2This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person in June 2014.
- F3Shares were acquired upon the exercise of outstanding stock options at $4.49 per share.